リパーゼ市場の2030年までの予測：由来別、形態別、用途別、地域別の世界分析

Stratistics MRCによると、世界のリパーゼ市場は2024年に6億8,920万米ドルを占め、予測期間中にCAGR 12.5％で成長し、2030年には13億9,720万米ドルに達すると予想されています。

リパーゼは、体内の脂質（脂肪）の消化と代謝に不可欠な酵素です。主に膵臓で生産されるリパーゼは、トリグリセリドの遊離脂肪酸とグリセロールへの分解を促進し、腸での吸収を可能にします。このプロセスは、エネルギー産生と様々な細胞成分の合成に不可欠です。リパーゼは、脂肪（脂質）をより小さな分子、主に脂肪酸とグリセロールに分解する重要な酵素です。この酵素は、脂肪を乳化し、リパーゼが作用する表面積を増やす胆汁酸塩の存在下で効果的に働きます。

高まる健康意識

食生活や健康全般に対する意識が高まるにつれ、リパーゼのような酵素が代謝機能を最適に維持する上で果たす役割も認識されるようになっています。リパーゼは、食餌性脂肪を脂肪酸とグリセロールに分解し、エネルギー産生と栄養吸収に不可欠な働きをします。このような意識の高まりから、消化器系の健康に関する関心が高まり、リパーゼ活性を高める酵素の豊富な食品やサプリメントが注目されるようになった。さらに、体重、コレステロール値、胃腸障害の管理におけるリパーゼの利点を強調する調査が、この動向に拍車をかけています。

環境問題

リパーゼは食品、バイオ燃料、医薬品など様々な産業に不可欠な酵素です。環境の持続可能性をめぐる規制の枠組みが強化されるにつれ、メーカーは生産効率を維持しながらエコロジカル・フットプリントを最小限に抑えるという課題に直面しています。例えば、リパーゼの抽出や製剤化に有機溶媒や刺激の強い化学薬品を使用することは、汚染や生息地の劣化につながる可能性があります。しかし、環境に優しい製品への需要の高まりから、再生可能な資源に由来する生体触媒へのシフトが促されており、必ずしも十分な量や望ましい活性が得られるとは限らないです。

医薬品におけるリパーゼの使用の増加

脂質の加水分解を触媒する酵素であるリパーゼは、脂質をベースとしたドラッグデリバリーシステムの製剤化など、様々な治療プロセスにおいて重要な役割を果たしています。脂質構造を改変するリパーゼの能力は、疎水性薬物の溶解性とバイオアベイラビリティを改善し、より効果的な治療につながります。リパーゼは生物活性化合物の合成や、薬物の安定性や吸収性を高めるプロドラッグの開発にも利用されています。さらに、バイオテクノロジーの進歩により、遺伝子工学やタンパク質の最適化を通じて、より効率的で安定したリパーゼの生産が可能になりつつあります。

市場の飽和

市場の飽和とは、製品の供給が需要を上回り、売上が伸び悩む状況を指します。リパーゼは食品、医薬品、バイオ燃料などの産業で広く使用されている酵素であるが、飽和は大きな課題となりうる。リパーゼ市場に参入する企業が増えると、競争が激化して価格が下落し、既存企業の利益率が圧迫されます。また、類似製品の乱立はブランドの差別化を困難にし、顧客ロイヤルティや市場シェアの低下を招く。また、供給過剰は生産能力の活用不足を招き、経営効率にさらなる影響を与える可能性があります。

COVID-19の影響：

COVID-19の流行は、リパーゼのような酵素研究を含むヘルスケアの様々な側面に大きな影響を与えました。脂肪の消化と代謝に不可欠な酵素であるリパーゼは、研究者がこの病気におけるその役割を探る中で、焦点となった。パンデミックの間、多くの患者が脂質プロファイルに変化を示し、COVID-19が正常なリパーゼ活性を阻害する可能性があることが研究で示されました。この混乱は、ウイルスによる炎症や代謝の変化と関連している可能性があり、脂肪代謝に影響を与え、罹患者に合併症を引き起こす可能性があります。しかし、パンデミックはヘルスケアサービスへのアクセスを制限し、膵炎のようなリパーゼ値の異常に関連する症状の定期的な検査と管理を遅らせています。

予測期間中、動物由来セグメントが最大となる見込み

食品、飼料、バイオ燃料産業など、様々な用途における脂質の消化・利用効率の高さから、動物由来セグメントは予測期間中に最大となる見込みです。リパーゼは油脂の加水分解を触媒する酵素で、トリグリセリドを遊離脂肪酸とグリセロールに分解する際に重要な役割を果たします。リパーゼの生産条件を最適化することで、例えば、特定の動物性原料の選択、発酵プロセスの最適化、遺伝子工学技術の採用などにより、研究者はこれらの酵素の収量と活性の向上を目指しています。リパーゼの強化は、家畜の脂肪消化の改善、栄養吸収の改善、人間の食事における脂肪酸の生物学的利用能の向上につながります。

予測期間中のCAGRは液体セグメントが最も高いと予想される

リパーゼが最もよく機能するのは主に液体環境であり、予測期間中、液体セグメントのCAGRが最も高くなると予想されます。リパーゼは脂肪を脂肪酸とグリセロールに分解するのに重要であり、消化や様々な産業用途で重要な役割を果たしています。液体培地内の温度、pH、基質濃度などのパラメーターを調整することで、研究者はリパーゼ活性と安定性を大幅に向上させることができます。さらに、補酵素や界面活性剤を加えることで、リパーゼの効率をさらに高めることができ、脂肪の乳化や加水分解をより効果的に行うことができます。

最もシェアの高い地域

消費者が胃腸の健康をサポートする製品を求める傾向が強まっていることから、推定期間中、欧州地域が市場で最大のシェアを占めると予想されます。脂肪の消化を助ける必須酵素であるリパーゼは、同地域の栄養補助食品や機能性食品で人気を集めています。人々の健康志向が高まり、酵素の効能について知るようになるにつれて、消化を改善し、鼓腸を抑え、栄養吸収を高めることに焦点が当てられ、リパーゼ製品に対する需要が高まっています。

CAGRが最も高い地域：

欧州地域は、革新的な治療ソリューションに対する需要の高まりに牽引され、予測期間中に収益性の高い成長を示すと推定されます。脂肪の加水分解を触媒する酵素であるリパーゼは、肥満管理、消化器系の健康、代謝障害など、さまざまな医療・医薬用途で重要な役割を果たしています。研究者がより効果的なリパーゼ製剤の開発に注力する中、バイオテクノロジーと酵素学の進歩は、より強力で標的を絞った酵素療法の創造につながっています。製薬研究に対する規制当局の支援と資金提供により、学界と産業界の協力が促進され、その結果、研究室での知見が臨床応用へと迅速に移行しています。

無料カスタマイズサービス：

本レポートをご購読のお客様には、以下の無料カスタマイズオプションのいずれかをご利用いただけます：

• 企業プロファイル
  • 追加市場プレイヤーの包括的プロファイリング（3社まで）
  • 主要企業のSWOT分析（3社まで）
• 地域セグメンテーション
  • 顧客の関心に応じた主要国の市場推計・予測・CAGR（注：フィージビリティチェックによる）
• 競合ベンチマーキング
  • 製品ポートフォリオ、地理的プレゼンス、戦略的提携に基づく主要企業のベンチマーキング

目次

第1章 エグゼクティブサマリー

第2章 序文

• 概要
• ステークホルダー
• 調査範囲
• 調査手法
  • データマイニング
  • データ分析
  • データ検証
  • 調査アプローチ
• 調査情報源
  • 1次調査情報源
  • 2次調査情報源
  • 前提条件

第3章 市場動向分析

• 促進要因
• 抑制要因
• 機会
• 脅威
• 用途分析
• 新興市場
• COVID-19の影響

第4章 ポーターのファイブフォース分析

• 供給企業の交渉力
• 買い手の交渉力
• 代替品の脅威
• 新規参入業者の脅威
• 競争企業間の敵対関係

第5章 世界のリパーゼ市場：由来別

• 動物由来
• 微生物由来
• 植物由来

第6章 世界のリパーゼ市場：形態別

• 粉
• 液体
• ゲル

第7章 世界のリパーゼ市場：用途別

• 動物飼料
• 化学薬品
• パン・菓子類
• 食品・飲料
• 栄養補助食品
• その他の用途

第8章 世界のリパーゼ市場：地域別

• 北米
  • 米国
  • カナダ
  • メキシコ
• 欧州
  • ドイツ
  • 英国
  • イタリア
  • フランス
  • スペイン
  • その他欧州
• アジア太平洋
  • 日本
  • 中国
  • インド
  • オーストラリア
  • ニュージーランド
  • 韓国
  • その他アジア太平洋地域
• 南米
  • アルゼンチン
  • ブラジル
  • チリ
  • その他南米
• 中東・アフリカ
  • サウジアラビア
  • アラブ首長国連邦
  • カタール
  • 南アフリカ
  • その他中東とアフリカ

第9章 主な発展

• 契約、パートナーシップ、コラボレーション、合弁事業
• 買収と合併
• 新製品発売
• 事業拡大
• その他の主要戦略

第10章 企業プロファイリング

• BASF SE
• AB Enzymes GmbH
• Advanced Enzymes Technologies Ltd
• Amano Enzyme Inc
• DuPont de Nemours, Inc
• Enzyme Development Corporation
• Evonik Industries AG
• FMC Corporation
• Novozymes A/S
• Roche Holding AG
• Syngenta AG

List of Tables

• Table 1 Global Lipase Market Outlook, By Region (2022-2030) ($MN)
• Table 2 Global Lipase Market Outlook, By Source (2022-2030) ($MN)
• Table 3 Global Lipase Market Outlook, By Animal Source (2022-2030) ($MN)
• Table 4 Global Lipase Market Outlook, By Microbial Source (2022-2030) ($MN)
• Table 5 Global Lipase Market Outlook, By Plant Source (2022-2030) ($MN)
• Table 6 Global Lipase Market Outlook, By Form (2022-2030) ($MN)
• Table 7 Global Lipase Market Outlook, By Powder (2022-2030) ($MN)
• Table 8 Global Lipase Market Outlook, By Liquid (2022-2030) ($MN)
• Table 9 Global Lipase Market Outlook, By Gel (2022-2030) ($MN)
• Table 10 Global Lipase Market Outlook, By Application (2022-2030) ($MN)
• Table 11 Global Lipase Market Outlook, By Animal Feed (2022-2030) ($MN)
• Table 12 Global Lipase Market Outlook, By Chemicals (2022-2030) ($MN)
• Table 13 Global Lipase Market Outlook, By Bakery and Confectionery (2022-2030) ($MN)
• Table 14 Global Lipase Market Outlook, By Food & Beverages (2022-2030) ($MN)
• Table 15 Global Lipase Market Outlook, By Nutraceuticals (2022-2030) ($MN)
• Table 16 Global Lipase Market Outlook, By Other Applications (2022-2030) ($MN)
• Table 17 North America Lipase Market Outlook, By Country (2022-2030) ($MN)
• Table 18 North America Lipase Market Outlook, By Source (2022-2030) ($MN)
• Table 19 North America Lipase Market Outlook, By Animal Source (2022-2030) ($MN)
• Table 20 North America Lipase Market Outlook, By Microbial Source (2022-2030) ($MN)
• Table 21 North America Lipase Market Outlook, By Plant Source (2022-2030) ($MN)
• Table 22 North America Lipase Market Outlook, By Form (2022-2030) ($MN)
• Table 23 North America Lipase Market Outlook, By Powder (2022-2030) ($MN)
• Table 24 North America Lipase Market Outlook, By Liquid (2022-2030) ($MN)
• Table 25 North America Lipase Market Outlook, By Gel (2022-2030) ($MN)
• Table 26 North America Lipase Market Outlook, By Application (2022-2030) ($MN)
• Table 27 North America Lipase Market Outlook, By Animal Feed (2022-2030) ($MN)
• Table 28 North America Lipase Market Outlook, By Chemicals (2022-2030) ($MN)
• Table 29 North America Lipase Market Outlook, By Bakery and Confectionery (2022-2030) ($MN)
• Table 30 North America Lipase Market Outlook, By Food & Beverages (2022-2030) ($MN)
• Table 31 North America Lipase Market Outlook, By Nutraceuticals (2022-2030) ($MN)
• Table 32 North America Lipase Market Outlook, By Other Applications (2022-2030) ($MN)
• Table 33 Europe Lipase Market Outlook, By Country (2022-2030) ($MN)
• Table 34 Europe Lipase Market Outlook, By Source (2022-2030) ($MN)
• Table 35 Europe Lipase Market Outlook, By Animal Source (2022-2030) ($MN)
• Table 36 Europe Lipase Market Outlook, By Microbial Source (2022-2030) ($MN)
• Table 37 Europe Lipase Market Outlook, By Plant Source (2022-2030) ($MN)
• Table 38 Europe Lipase Market Outlook, By Form (2022-2030) ($MN)
• Table 39 Europe Lipase Market Outlook, By Powder (2022-2030) ($MN)
• Table 40 Europe Lipase Market Outlook, By Liquid (2022-2030) ($MN)
• Table 41 Europe Lipase Market Outlook, By Gel (2022-2030) ($MN)
• Table 42 Europe Lipase Market Outlook, By Application (2022-2030) ($MN)
• Table 43 Europe Lipase Market Outlook, By Animal Feed (2022-2030) ($MN)
• Table 44 Europe Lipase Market Outlook, By Chemicals (2022-2030) ($MN)
• Table 45 Europe Lipase Market Outlook, By Bakery and Confectionery (2022-2030) ($MN)
• Table 46 Europe Lipase Market Outlook, By Food & Beverages (2022-2030) ($MN)
• Table 47 Europe Lipase Market Outlook, By Nutraceuticals (2022-2030) ($MN)
• Table 48 Europe Lipase Market Outlook, By Other Applications (2022-2030) ($MN)
• Table 49 Asia Pacific Lipase Market Outlook, By Country (2022-2030) ($MN)
• Table 50 Asia Pacific Lipase Market Outlook, By Source (2022-2030) ($MN)
• Table 51 Asia Pacific Lipase Market Outlook, By Animal Source (2022-2030) ($MN)
• Table 52 Asia Pacific Lipase Market Outlook, By Microbial Source (2022-2030) ($MN)
• Table 53 Asia Pacific Lipase Market Outlook, By Plant Source (2022-2030) ($MN)
• Table 54 Asia Pacific Lipase Market Outlook, By Form (2022-2030) ($MN)
• Table 55 Asia Pacific Lipase Market Outlook, By Powder (2022-2030) ($MN)
• Table 56 Asia Pacific Lipase Market Outlook, By Liquid (2022-2030) ($MN)
• Table 57 Asia Pacific Lipase Market Outlook, By Gel (2022-2030) ($MN)
• Table 58 Asia Pacific Lipase Market Outlook, By Application (2022-2030) ($MN)
• Table 59 Asia Pacific Lipase Market Outlook, By Animal Feed (2022-2030) ($MN)
• Table 60 Asia Pacific Lipase Market Outlook, By Chemicals (2022-2030) ($MN)
• Table 61 Asia Pacific Lipase Market Outlook, By Bakery and Confectionery (2022-2030) ($MN)
• Table 62 Asia Pacific Lipase Market Outlook, By Food & Beverages (2022-2030) ($MN)
• Table 63 Asia Pacific Lipase Market Outlook, By Nutraceuticals (2022-2030) ($MN)
• Table 64 Asia Pacific Lipase Market Outlook, By Other Applications (2022-2030) ($MN)
• Table 65 South America Lipase Market Outlook, By Country (2022-2030) ($MN)
• Table 66 South America Lipase Market Outlook, By Source (2022-2030) ($MN)
• Table 67 South America Lipase Market Outlook, By Animal Source (2022-2030) ($MN)
• Table 68 South America Lipase Market Outlook, By Microbial Source (2022-2030) ($MN)
• Table 69 South America Lipase Market Outlook, By Plant Source (2022-2030) ($MN)
• Table 70 South America Lipase Market Outlook, By Form (2022-2030) ($MN)
• Table 71 South America Lipase Market Outlook, By Powder (2022-2030) ($MN)
• Table 72 South America Lipase Market Outlook, By Liquid (2022-2030) ($MN)
• Table 73 South America Lipase Market Outlook, By Gel (2022-2030) ($MN)
• Table 74 South America Lipase Market Outlook, By Application (2022-2030) ($MN)
• Table 75 South America Lipase Market Outlook, By Animal Feed (2022-2030) ($MN)
• Table 76 South America Lipase Market Outlook, By Chemicals (2022-2030) ($MN)
• Table 77 South America Lipase Market Outlook, By Bakery and Confectionery (2022-2030) ($MN)
• Table 78 South America Lipase Market Outlook, By Food & Beverages (2022-2030) ($MN)
• Table 79 South America Lipase Market Outlook, By Nutraceuticals (2022-2030) ($MN)
• Table 80 South America Lipase Market Outlook, By Other Applications (2022-2030) ($MN)
• Table 81 Middle East & Africa Lipase Market Outlook, By Country (2022-2030) ($MN)
• Table 82 Middle East & Africa Lipase Market Outlook, By Source (2022-2030) ($MN)
• Table 83 Middle East & Africa Lipase Market Outlook, By Animal Source (2022-2030) ($MN)
• Table 84 Middle East & Africa Lipase Market Outlook, By Microbial Source (2022-2030) ($MN)
• Table 85 Middle East & Africa Lipase Market Outlook, By Plant Source (2022-2030) ($MN)
• Table 86 Middle East & Africa Lipase Market Outlook, By Form (2022-2030) ($MN)
• Table 87 Middle East & Africa Lipase Market Outlook, By Powder (2022-2030) ($MN)
• Table 88 Middle East & Africa Lipase Market Outlook, By Liquid (2022-2030) ($MN)
• Table 89 Middle East & Africa Lipase Market Outlook, By Gel (2022-2030) ($MN)
• Table 90 Middle East & Africa Lipase Market Outlook, By Application (2022-2030) ($MN)
• Table 91 Middle East & Africa Lipase Market Outlook, By Animal Feed (2022-2030) ($MN)
• Table 92 Middle East & Africa Lipase Market Outlook, By Chemicals (2022-2030) ($MN)
• Table 93 Middle East & Africa Lipase Market Outlook, By Bakery and Confectionery (2022-2030) ($MN)
• Table 94 Middle East & Africa Lipase Market Outlook, By Food & Beverages (2022-2030) ($MN)
• Table 95 Middle East & Africa Lipase Market Outlook, By Nutraceuticals (2022-2030) ($MN)
• Table 96 Middle East & Africa Lipase Market Outlook, By Other Applications (2022-2030) ($MN)

According to Stratistics MRC, the Global Lipase Market is accounted for $689.2 million in 2024 and is expected to reach $1,397.2 million by 2030 growing at a CAGR of 12.5% during the forecast period. Lipase is an enzyme crucial for the digestion and metabolism of lipids, or fats, in the body. Produced primarily in the pancreas, lipase facilitates the breakdown of triglycerides into free fatty acids and glycerol, enabling their absorption in the intestines. This process is essential for energy production and the synthesis of various cellular components. Lipase is an essential enzyme responsible for breaking down fats (lipids) into smaller molecules, primarily fatty acids and glycerol. The enzyme works effectively in the presence of bile salts, which emulsify fats, increasing the surface area for lipase action.

Market Dynamics:

Driver:

Rising health awareness

As individuals become more conscious of their dietary choices and overall wellness, they are increasingly recognizing the role of enzymes like lipase in maintaining optimal metabolic function. Lipase facilitates the breakdown of dietary fats into fatty acids and glycerol, which are essential for energy production and nutrient absorption. This growing awareness has led to a surge in interest surrounding digestive health, prompting people to seek out enzyme-rich foods and supplements that can enhance lipase activity. Additionally, research highlighting the benefits of lipase in managing weight, cholesterol levels, and gastrointestinal disorders has further fueled this trend.

Restraint:

Environmental concerns

Environmental concerns are increasingly impacting the production and application of lipases, enzymes critical for various industries, including food, biofuels, and pharmaceuticals. As regulatory frameworks tighten around environmental sustainability, manufacturers face challenges in maintaining production efficiency while minimizing ecological footprints. For instance, the use of organic solvents and harsh chemicals in lipase extraction and formulation can lead to pollution and habitat degradation. However, the growing demand for eco-friendly products has prompted a shift towards biocatalysts derived from renewable resources, which may not always yield sufficient quantities or desired activities.

Opportunity:

Increasing use of lipases in pharmaceuticals

Lipases, enzymes that catalyze the hydrolysis of lipids, play a crucial role in various therapeutic processes, including the formulation of lipid-based drug delivery systems. Their ability to modify lipid structures can improve the solubility and bioavailability of hydrophobic drugs, leading to more effective treatments. Lipases are employed in the synthesis of bioactive compounds and the development of prodrugs, which can enhance drug stability and absorption. Furthermore, the ongoing advancements in biotechnology are enabling the production of more efficient and stable lipases through genetic engineering and protein optimization.

Threat:

Market saturation

Market saturation refers to a situation where the supply of a product exceeds its demand, leading to a stagnation in sales growth. In the context of lipase, an enzyme used widely in industries such as food, pharmaceuticals, and biofuels, saturation can pose significant challenges. As more companies enter the lipase market, the increased competition drives prices down, squeezing profit margins for existing players. The proliferation of similar products can make it difficult for brands to differentiate themselves, resulting in reduced customer loyalty and market share. This oversupply may also lead to underutilization of production capacities, further impacting operational efficiencies.

Covid-19 Impact:

The COVID-19 pandemic significantly impacted various aspects of healthcare, including enzyme studies like lipase. Lipase, an enzyme crucial for fat digestion and metabolism, became a focal point as researchers explored its role in the disease. During the pandemic, many patients exhibited altered lipid profiles, with studies indicating that COVID-19 could disrupt normal lipase activity. This disruption may be linked to inflammation and metabolic changes caused by the virus, affecting fat metabolism and potentially leading to complications in affected individuals. However, the pandemic limited access to healthcare services, delaying routine testing and management of conditions related to abnormal lipase levels, such as pancreatitis.

The Animal Source segment is expected to be the largest during the forecast period

Animal Source segment is expected to be the largest during the forecast period due to the efficiency of lipid digestion and utilization in various applications, including food, feed, and biofuel industries. Lipases are enzymes that catalyze the hydrolysis of fats and oils, playing a crucial role in breaking down triglycerides into free fatty acids and glycerol. By optimizing conditions for lipase production, such as selecting specific animal sources, optimizing fermentation processes, and employing genetic engineering techniques, researchers aim to increase the yield and activity of these enzymes. Enhanced lipase can lead to improved fat digestion in livestock, better nutrient absorption, and increased bioavailability of fatty acids in human diets.

The Liquid segment is expected to have the highest CAGR during the forecast period

Liquid segment is expected to have the highest CAGR during the forecast period under which this enzyme functions best, primarily in liquid environments. Lipase is crucial for the breakdown of fats into fatty acids and glycerol, playing a vital role in digestion and various industrial applications. By adjusting parameters such as temperature, pH, and substrate concentration within the liquid medium, researchers can significantly increase lipase activity and stability. Moreover, the addition of co-factors or surfactants can further enhance lipase efficiency, allowing for more effective fat emulsification and hydrolysis.

Region with largest share:

Europe region is anticipated to command the largest share of the market over the extrapolated period as consumers increasingly seek products that support gastrointestinal well-being. Lipase, an essential enzyme that aids in the digestion of fats, is gaining traction in dietary supplements and functional foods across the region. As people become more health-conscious and informed about the benefits of enzymes, the demand for lipase products is rising, driven by a focus on improving digestion, reducing bloating, and enhancing nutrient absorption.

Region with highest CAGR:

Europe region is estimated to witness profitable growth during the projected period driven by the growing demand for innovative therapeutic solutions. Lipases, enzymes that catalyze the hydrolysis of fats, play a crucial role in various medical and pharmaceutical applications, including obesity management, digestive health, and metabolic disorders. As researchers focus on developing more effective lipase formulations, advancements in biotechnology and enzymology are leading to the creation of more potent and targeted enzyme therapies. Regulatory support and funding for pharmaceutical research are fostering collaboration between academia and industry, resulting in the rapid translation of laboratory findings into clinical applications.

Key players in the market

Some of the key players in Lipase market include BASF SE, AB Enzymes GmbH, Advanced Enzymes Technologies Ltd, Amano Enzyme Inc, DuPont de Nemours, Inc, Enzyme Development Corporation, Evonik Industries AG, FMC Corporation, Novozymes A/S, Roche Holding AG and Syngenta AG.

Key Developments:

In September 2024, Novozymes and Chr. Hansen announced that their future combined company will be named Novonesis, symbolizing "A new beginning" for their collaboration in biosolutions.

In September 2024, Chr. Hansen launched SPICEIT, a new cheese product that utilizes lipases to enhance flavor by converting milk-fat triglycerides into unsaturated fats, creating a unique taste experience.

In August 2024, Associated British Foods (ABF) acquired a majority stake in a leading Indian microbial lipase manufacturer, Enzyme Bio-Systems Ltd. This strategic move allows ABF to strengthen its presence in the rapidly growing Asia-Pacific market and broaden its portfolio of specialty enzymes.

In August 2024, E. I. Du Pont De Nemours and Company announced the expansion of its enzyme production facility in North Carolina. This expansion aims to increase the production capacity of microbial lipases, catering to the growing demand in the food and beverage industry.

Sources Covered:

• Animal Source
• Microbial Source
• Plant Source

Forms Covered:

• Powder
• Liquid
• Gel

Applications Covered:

• Animal Feed
• Chemicals
• Bakery and Confectionery
• Food & Beverages
• Nutraceuticals
• Other Applications

Regions Covered:

• North America
  • US
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • Italy
  • France
  • Spain
  • Rest of Europe
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • New Zealand
  • South Korea
  • Rest of Asia Pacific
• South America
  • Argentina
  • Brazil
  • Chile
  • Rest of South America
• Middle East & Africa
  • Saudi Arabia
  • UAE
  • Qatar
  • South Africa
  • Rest of Middle East & Africa

What our report offers:

• Market share assessments for the regional and country-level segments
• Strategic recommendations for the new entrants
• Covers Market data for the years 2022, 2023, 2024, 2026, and 2030
• Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
• Strategic recommendations in key business segments based on the market estimations
• Competitive landscaping mapping the key common trends
• Company profiling with detailed strategies, financials, and recent developments
• Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

• Company Profiling
  • Comprehensive profiling of additional market players (up to 3)
  • SWOT Analysis of key players (up to 3)
• Regional Segmentation
  • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
  • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

• 2.1 Abstract
• 2.2 Stake Holders
• 2.3 Research Scope
• 2.4 Research Methodology
  • 2.4.1 Data Mining
  • 2.4.2 Data Analysis
  • 2.4.3 Data Validation
  • 2.4.4 Research Approach
• 2.5 Research Sources
  • 2.5.1 Primary Research Sources
  • 2.5.2 Secondary Research Sources
  • 2.5.3 Assumptions

3 Market Trend Analysis

• 3.1 Introduction
• 3.2 Drivers
• 3.3 Restraints
• 3.4 Opportunities
• 3.5 Threats
• 3.6 Application Analysis
• 3.7 Emerging Markets
• 3.8 Impact of Covid-19

4 Porters Five Force Analysis

• 4.1 Bargaining power of suppliers
• 4.2 Bargaining power of buyers
• 4.3 Threat of substitutes
• 4.4 Threat of new entrants
• 4.5 Competitive rivalry

5 Global Lipase Market, By Source

• 5.1 Introduction
• 5.2 Animal Source
• 5.3 Microbial Source
• 5.4 Plant Source

6 Global Lipase Market, By Form

• 6.1 Introduction
• 6.2 Powder
• 6.3 Liquid
• 6.4 Gel

7 Global Lipase Market, By Application

• 7.1 Introduction
• 7.2 Animal Feed
• 7.3 Chemicals
• 7.4 Bakery and Confectionery
• 7.5 Food & Beverages
• 7.6 Nutraceuticals
• 7.7 Other Applications

8 Global Lipase Market, By Geography

• 8.1 Introduction
• 8.2 North America
  • 8.2.1 US
  • 8.2.2 Canada
  • 8.2.3 Mexico
• 8.3 Europe
  • 8.3.1 Germany
  • 8.3.2 UK
  • 8.3.3 Italy
  • 8.3.4 France
  • 8.3.5 Spain
  • 8.3.6 Rest of Europe
• 8.4 Asia Pacific
  • 8.4.1 Japan
  • 8.4.2 China
  • 8.4.3 India
  • 8.4.4 Australia
  • 8.4.5 New Zealand
  • 8.4.6 South Korea
  • 8.4.7 Rest of Asia Pacific
• 8.5 South America
  • 8.5.1 Argentina
  • 8.5.2 Brazil
  • 8.5.3 Chile
  • 8.5.4 Rest of South America
• 8.6 Middle East & Africa
  • 8.6.1 Saudi Arabia
  • 8.6.2 UAE
  • 8.6.3 Qatar
  • 8.6.4 South Africa
  • 8.6.5 Rest of Middle East & Africa

9 Key Developments

• 9.1 Agreements, Partnerships, Collaborations and Joint Ventures
• 9.2 Acquisitions & Mergers
• 9.3 New Product Launch
• 9.4 Expansions
• 9.5 Other Key Strategies

10 Company Profiling

• 10.1 BASF SE
• 10.2 AB Enzymes GmbH
• 10.3 Advanced Enzymes Technologies Ltd
• 10.4 Amano Enzyme Inc
• 10.5 DuPont de Nemours, Inc
• 10.6 Enzyme Development Corporation
• 10.7 Evonik Industries AG
• 10.8 FMC Corporation
• 10.9 Novozymes A/S
• 10.10 Roche Holding AG
• 10.11 Syngenta AG